Advances in the Treatments of Systemic Vasculitides
- First Online:
- Cite this article as:
- Guillevin, L. Clinic Rev Allerg Immunol (2008) 35: 72. doi:10.1007/s12016-007-8068-4
- 89 Downloads
Necrotizing systemic vasculitides are severe diseases in which prognosis improved since steroids and cytotoxic agents have been prescribed. The outcome is now better, and remission is obtained in more than 80% of patients. In this review paper, we will cover the indications of conventional treatments and new biotherapies and other therapies. The strategies that improve patient’s outcome are discussed in the light of the prospective trials organized by international research groups.